TY - JOUR T1 - Cardiopulmonary exercise testing of patients with metastatic castrate-resistant prostate cancer as screening for vigorous exercise medicine prescription. JO - JCO Global Oncology UR - http://dx.doi.org/10.1200/go.2023.9.supplement_1.80 PY - 2023/08/01 AU - Newton RU AU - Hart NH AU - Kenfield SA AU - Galvao DA AU - Courneya KS AU - Ryan CM AU - Chan JM AU - Catto JWF AU - Winters-Stone KM AU - Van Hemelrijck M AU - Wylie H et al ED - DO - DOI: 10.1200/go.2023.9.supplement_1.80 PB - American Society of Clinical Oncology (ASCO) VL - 9 IS - Supplement_1 SP - 80 EP - 80 Y2 - 2025/04/09 ER -